Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gunjan Sinha

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Nature Medicine|March 3, 2004
Profile: Otmar WiestlerGunjan Sinha
Nature Medicine|October 2, 2004
Inflamed brains can trigger the blues, studies suggestGunjan Sinha
Journal of the National Cancer Institute|November 2, 2006
Geriatric oncology aims for clinical trialsGunjan Sinha
Nature Biotechnology|December 10, 2014
Listeria vaccines join the checkpoint frenzyGunjan Sinha
Journal of the National Cancer Institute|November 26, 2014
Overcoming mantle cell lymphoma's ibrutinib resistanceGunjan Sinha
Nature Biotechnology|July 12, 2012
Coalition aims to accelerate translation of cell therapiesGunjan Sinha
Nature Biotechnology|March 10, 2015
Weight loss 'electroceutical' device wins FDA okayGunjan Sinha
Journal of the National Cancer Institute|July 31, 2008
Gene testing to tailor breast cancer therapy has arrived--is it ready for the clinic?Gunjan Sinha
Nature Biotechnology|February 9, 2011
Trade secrets in balance as agencies issue new transparency rulesGunjan Sinha
Scientific American|February 4, 2003
Bad medicine. Why data from drug companies may be hard to swallowGunjan Sinha
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Nature Medicine|March 3, 2004
Profile: Otmar WiestlerGunjan Sinha
Nature Medicine|October 2, 2004
Inflamed brains can trigger the blues, studies suggestGunjan Sinha
Journal of the National Cancer Institute|November 2, 2006
Geriatric oncology aims for clinical trialsGunjan Sinha
Nature Biotechnology|December 10, 2014
Listeria vaccines join the checkpoint frenzyGunjan Sinha
Journal of the National Cancer Institute|November 26, 2014
Overcoming mantle cell lymphoma's ibrutinib resistanceGunjan Sinha
Nature Biotechnology|July 12, 2012
Coalition aims to accelerate translation of cell therapiesGunjan Sinha
Nature Biotechnology|March 10, 2015
Weight loss 'electroceutical' device wins FDA okayGunjan Sinha
Journal of the National Cancer Institute|July 31, 2008
Gene testing to tailor breast cancer therapy has arrived--is it ready for the clinic?Gunjan Sinha
Nature Biotechnology|February 9, 2011
Trade secrets in balance as agencies issue new transparency rulesGunjan Sinha
Scientific American|February 4, 2003
Bad medicine. Why data from drug companies may be hard to swallowGunjan Sinha
Pageof 8